Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19

We present a multicenter case series from 9 centers in the United States of patients with acute neurological deficits consistent with AIS and COVID-19 who were treated with IV tPA.Results: We identified 13 patients (mean age 62 ( ±9.8) years, 9 (69.2%) male).
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research